Skip to main content

Reveos Select CPD with AS-5 Red Cell Preservative Solution For Collection Of 500ml Of Blood

Verified·Apr 23, 2026
Manufacturer
Terumo Corporation
NDC
82906-506
ICD-10 indication
D64.9

Affordability Check

How much will you actually pay for Reveos Select CPD with AS-5 Red Cell Preservative Solution For Collection Of 500ml Of Blood?

In 30 seconds, see every legitimate way to afford Reveos Select CPD with AS-5 Red Cell Preservative Solution For Collection Of 500ml Of Blood — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Reveos Select CPD with AS-5 Red Cell Preservative Solution For Collection Of 500ml Of Blood

A sterile blood collection system consisting of a primary bag containing Citrate Phosphate Dextrose (CPD) anticoagulant and a satellite bag containing AS-5 (Optisol) additive solution. It is indicated for the collection of 500 mL of whole blood and the subsequent preservation of red blood cells for up to 42 days.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Reveos Select CPD with AS-5 Red Cell Preservative Solution For Collection Of 500ml Of Blood. Official source: DailyMed (NLM) · Label effective Jan 14, 2025

Indications and usage
1 INDICATIONS AND USAGE The Reveos ® SELECT set is intended to collect a unit of whole blood and to process the whole blood unit on the Reveos Automated Blood Processing System, producing blood components. Rx only. The Reveos ® SELECT set is intended to collect a unit of whole blood and to process the whole blood unit on the Reveos Automated Blood Processing System, producing blood components. ( 1 ) Rx only. ( 1 )
Dosage and administration
2 DOSAGE AND ADMINISTRATION Follow the instructions for collecting blood with the Reveos SELECT set. ( 2 ) Follow the instructions for post-processing and red blood cell leukoreduction with the Reveos SELECT set. ( 2 ) Set Diagram 1 Whole blood bag 7 Sample/diversion bag A, C: Y connector 2 Interim platelet unit (IPU) bag 8 Needle B, G: Blue clamp 3 Plasma bag 9 Needle injury protector (NIP) D, F, H, J: CLIKTIP frangible connector 4 Plasma cryoprecipitate reduced bag 10 Sample tube holder/luer adapter E: White clamp 5 Red blood cell (RBC) bag 11 Cross-connector 6 Residual leukocyte bag 12 RBC leukoreduction filter This document provides blood collection and post-processing instructions specific to the Reveos SELECT set. For warnings, cautions, and instructions on processing whole blood with the Reveos system, see the Reveos system operator's manual. Note : Refer to the instructions for use provided by the manufacturer of your tubing sealer to ensure that the tubing sealer is appropriate for the tubing on the blood bag set. Note : You must validate the process for producing, storing, and handling Cryoprecipitated Antihemophilic Factor within your institution's standard operating procedure (SOP), including procedures for using the plasma cryoprecipitate reduced bag. Blood Collection Required Supplies: • Scale and/or blood mixing device • Tubing sealer • Evacuated blood collection tubes 1. If it is part of your institution's SOP, make a loose knot in the collection tubing between white clamp E and the whole blood bag. 2. Separate the sample/diversion bag from the other bags. 3. Load the bags onto a scale and/or blood mixing device according to your institution's SOP. Ensure that the whole blood bag and the sample bag are lower than the donor's arm. 4. Close blue clamp B. 5. Apply a blood pressure cuff or a tourniquet to the donor's arm. 6. Prepare the venipuncture site. 7. Twist the needle cap until the resistance stops and then pull the needle cap straight off. 8. Perform the venipuncture according to your institution's SOP. 9. Open blue clamp B. 10. Position the sample/diversion bag with blue clamp B at the top and the sample tube holder/luer adapter at the bottom (see Figure 1 ). Allow the desired volume of whole blood to flow into the sample/diversion bag. The nominal volume of the sample bag is 60 mL. When the volume reaches the marking, approximately 40 mL has been collected. 11. Close blue clamp B. 12. Break CLIKTIP D to allow the whole blood to flow into the whole blood bag. Bend the CLIKTIP in both directions to ensure that you break it completely. 13. Seal the sample/diversion tubing as near as possible to Y connector A. Seal the tubing according to your institution's SOP. 14. Invert the sample/diversion bag and transfer donor blood samples from the sample/diversion bag, using evacuated blood collection tubes. Transfer samples as soon as possible after venipuncture to avoid possible clot formation in the sample/diversion bag. a. Hold the sample/diversion bag and sample tube holder/luer adapter in one hand with blue clamp B positioned at the bottom (see Figure 2 ). b. Using the other hand, insert a blood collection tube firmly into the sample tube holder/luer adapter. After filling the blood collection tube, remove the tube from the sample tube holder. Repeat the process to take additional samples. 15. Mix the whole blood and the anticoagulant during collection according to your institution's SOP. 16. Collect the target volume of blood ± 10%, as specified on the whole blood bag label. 17. Close white clamp E and perform one of the following steps: If you made a knot in the collection tubing in step 1, tighten the knot firmly. If you did not make a knot in step 1, seal the collection tubing near CLIKTIP D. 18. Hold the needle hub and then slide the NIP partially over the needle hub (see Figure 3 ). 19. Gently pull on the tubing to withdraw the needle from the donor's arm and into the NIP until the needle locks securely (see Figure 4 ). 20. Seal the collection tubing near CLIKTIP D if you did not do so in step 17. Disconnect the sealed tubing that includes the needle and the sampling assembly. Dispose of the needle, the NIP, and the sample tube holder safely according to your institution's SOP and/or local regulations. 21. Immediately after collection is complete, invert the whole blood bag several times to thoroughly mix the whole blood and the anticoagulant. 22. If required, strip the blood in the collection tubing into the whole blood bag according to your institution's SOP. 23. Seal and disconnect the collection tubing between 1 in and 2 in (2.5 cm and 5.0 cm) away from the whole blood bag. Dispose of the collection tubing safely according to your institution's SOP and/or local regulations. 24. Place the whole blood unit into a temperature-controlled environment according to your institution's SOP. 25. Pack and transport the whole blood unit to the processing laboratory according to your institution's SOP. Figure 1: Sample/diversion bag Figure 2: Collecting a whole blood sample Figure 3: Sliding the NIP over the needle hub Figure 4: Withdrawing the needle into the NIP Post-Processing and Red Blood Cell Leukoreduction Required Supplies: • Leukoreduction rack • Tubing sealer 1. After processing, remove the plasma bag, the plasma cryoprecipitate reduced bag, the residual leukocyte bag, and the IPU bag from the organizer and handle them according to your institution's SOP. Note : You must rest and agitate the IPU prior to platelet pooling. For conditions for resting and agitating the IPU, see the platelet pooling set instructions for use. 2. Prepare a leukoreduction rack with a head height of at least 43½ in (110 cm). 3. Remove the RBC bag from the organizer. 4. Hang the RBC bag from the leukoreduction rack so that the filter hangs vertically. 5. Open blue clamp G. 6. Break CLIKTIP H. 7. Break CLIKTIP J. 8. Drain all of the additive solution through the filter and into the whole blood bag. 9. Close blue clamp G. 10. Gently mix the additive solution with the RBC unit in the whole blood bag. 11. Hang the whole blood bag on the leukoreduction rack. 12. Ensure that the tubing is free of kinks or other obstructions. 13. Open blue clamp G and allow the mixture of red blood cells and additive solution to flow through the leukoreduction filter. Do not squeeze the whole blood bag to increase the draining rate. Filtration is complete when the inlet side of the leukoreduction filter collapses and the red blood cells drain from the inlet side of the filter. 14. Seal the RBC tubing below the leukoreduction filter and disconnect the RBC bag. Ensure that the filter remains in a vertical position while you seal the tubing, as this prevents the loss of red blood cells. 15. Dispose of the whole blood bag and filter assembly safely according to your institution's SOP and/or local regulations. 16. Seal the line for sampling segments according to your institution's SOP. 17. Store the RBC product according to your institution's SOP. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever the solution and container permit. Set Diagram Figure 1 Figure 2 Figure 3 Figure 4
Contraindications
4 CONTRAINDICATIONS None. None. ( 4 )
Warnings and precautions
5 WARNINGS AND PRECAUTIONS Single-use product. Do not reuse. This product is intended to be single use only and is not intended to be reused or re-sterilized in any manner. Terumo Blood and Cell Technologies cannot ensure the functionality or sterility of the product if it is reused or re-sterilized. Reuse of a single-use disposable set may result in: Product performance issues due to loss of product integrity, including but not limited to the following: Fluid leaks Parts that are warped or deformed Plastics that are brittle and discolored Filters that have reduced filtration capabilities Viral infections such as hepatitis or human immunodeficiency virus (HIV) Bacterial infections Cross-contamination Any of these risks could result in serious injury or death. These risks are shared by product users, donors, patients, and recipients of the end product of the device. Inspect the packaging and the blood bag set prior to use. Do not use the set if any of the following conditions are present: There are tears or holes in the outer aluminum foil packaging or in the individual transparent packaging wrap. The tubing has severe kinks. The blood bag set is incorrectly assembled. The blood bag set is defective or damaged, or there are any leaks from the fluid-filled components of the set. Any clamps are closed. The needle cap is not in place. The solutions are cloudy or discolored or contain particulates. Using the blood bag set under these conditions may result in product contamination or poor performance during collection and/or processing. Note : It is normal to have some condensation in the outer aluminum foil pouch and individual transparent packaging wrap due to sterilization. The blood bag set is no longer sterile if any of the following conditions occur: You disconnect the sample/diversion bag before you seal the sample/diversion tubing. You remove blood samples before you seal the sample/diversion tubing. The integrity of the set is compromised for any reason. Manage the blood bag set according to your institution's SOP. Do not process whole blood less than 2 hours after collection. Processing blood too soon after collection may result in incomplete RBC leukoreduction and/or a reduced platelet yield. Residual leukocytes are a by-product of the processing procedure and contain mostly white blood cells (WBC), with some plasma, platelets, and red blood cells (RBC). Residual leukocytes are not intended for transfusion. Use aseptic technique during blood collection to ensure donor safety and product quality. Do not vent the blood bag set. Do not reuse. ( 5 ) Inspect the packaging and the blood bag set prior to use. ( 5 ) The blood bag set is no longer sterile under certain conditions. ( 5 ) Do not process whole blood less than 2 hours after collection. ( 5 ) Residual leukocytes are not intended for transfusion. ( 5 ) Use aseptic technique during blood collection to ensure donor safety and product quality. ( 5 ) Do not vent the blood bag set. ( 5 )
Adverse reactions
6. ADVERSE REACTIONS To report SUSPECTED ADVERSE REACTIONS, contact Terumo BCT, Inc. at 1-877-339-4228 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. To report SUSPECTED ADVERSE REACTIONS, contact Terumo BCT, Inc. at 1-877-339-4228 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. ( 6 )
Use in pregnancy
8 USE IN SPECIFIC POPULATIONS The Reveos SELECT set has not been adequately studied in controlled clinical trials with specific populations. The Reveos SELECT set has not been studied in controlled clinical trials with specific populations. ( 8 )

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.